KalVista Pharmaceuticals Aktie
22,88
EUR
+0,15
EUR
+0,66
%
26,84
USD
+0,12
USD
+0,43
%
Werbung
KalVista Pharmaceuticals Aktie Analyse
| 20.03.19 | KalVista Pharmaceuticals Buy | Needham & Company, LLC | |
| 21.09.18 | KalVista Pharmaceuticals Overweight | Cantor Fitzgerald | |
| 31.08.17 | KalVista Pharmaceuticals Buy | BTIG Research |
Werbung
Werbung